Clinical Expert Series
Assessment of New Technology in the Treatment of Idiopathic Menorrhagia and Uterine
Leiomyomata
Howard T. Sharp, MD
Obstet Gynecol 2006;108:990–1003
ACCME Accreditation
The American College of Obstetricians and Gynecologists (ACOG) is accredited by the Accreditation Council for Continuing
Medical Education (ACCME) to provide continuing medical education for physicians. (Continuing medical education credit for
“Assessment of New Technology in the Treatment of Idiopathic Menorrhagia and Uterine Leiomyomata” will be available
through October 2009.)
AMA PRA Category 1 CreditTM and ACOG Cognate Credit
The American College of Obstetricians and Gynecologists (ACOG) designates this educational activity for a maximum of 2
AMA PRA Category 1 CreditsTM or up to a maximum of 2 Category 1 ACOG cognate credits. Physicians should only claim
credit commensurate with the extent of their participation in the activity.
Disclosure Statement
Current guidelines state that continuing medical education (CME) providers must ensure that CME activities are free from the
control of any commercial interest. All authors, reviewers, and contributors have disclosed to ACOG all relevant financial
relationships with any commercial interests. The authors, reviewers, and contributors declare that neither they nor any business
associate nor any member of their immediate families has financial interest or other relationships with any manufacturer of
products or any providers of services discussed in this program. Any conflicts have been resolved through group and outside
review of all content.
To obtain credits, complete and return this form via one of two methods: e-mail (cognates@acog.org) or fax (202-484-1586). If
you are sending this form via e-mail, please save the document to your computer and e-mail it as an attachment. Credit will be
automatically recorded upon receipt and online transcripts will be updated twice monthly. ACOG Fellows may check their
transcripts online at http://www.acog.org. Please be sure to retain this form as confirmation of your program participation. If you
are not an ACOG member, it is not necessary to send a copy of your completed form to us.
1. Which global endometrial ablation technique does not require pretreatment?
Thermal balloon
Circulated hot fluid
Cryotherapy
RF electrosurgery
Microwave energy
CME Quiz for the Clinical Expert Series
Obstet Gynecol 2006;108:990–1003
Credit available through October 2009
Page 1 of 3
2. The “Postoperative Adverse Events Occurring Within Two Weeks of Surgery, Reported During FDA
Pivotal Trials” and the “United States FDA Manufacturer and User Facility Device Experience
(MAUDE) database” underline the importance of:
Proper training
Sounding the uterus
Ultrasonography
The use of a hysteroscope
Performing the procedure in an operating room
3. What maximum uterine cavity size as determined by uterine sound was a contraindication for the
uterine balloon and cryoablation techniques in the FDA trials?
6 cm
7 cm
8 cm
9 cm
10 cm
4. Which of the following is a relative contraindication to global endometrial ablation?
Desire to be pregnant in the future
Active urinary tract infection at the time of treatment
Suspected endometrial carcinoma
Prior transmural myomectomy
Uterine anomaly, for example, unicornuate uterus
5. If the transcervical method of permanent tubal sterilization is used, it is important to remember that
the Essure system is only FDA approved for use with the:
ThermaChoice (thermal balloon)
Hydro ThermAblator (circulated hot fluid)
Her Option (cryotherapy)
NovaSure (RF electrosurgery)
MEA (microwave energy)
CME Quiz for the Clinical Expert Series
Obstet Gynecol 2006;108:990–1003
Credit available through October 2009
Page 2 of 3
6. Which of the following techniques for treating myomata is not approved by the FDA for use in the
United States?
Laparoscopic uterine artery occlusion
Exablate 2000: magnetic resonance–guided focused ultrasonography
Temporary transvaginal uterine artery occlusion
Uterine artery embolization
7. List any changes, if any, that you will make in your practice as a result of reading this article:
ACOG ID Number:
Name:
Address:
City/State/Zip:
Actual time spent completing this activity (you may record up to 2 hours):
CME Quiz for the Clinical Expert Series
Obstet Gynecol 2006;108:990–1003
Credit available through October 2009
Page 3 of 3